These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22751903)

  • 21. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
    Rahman M; Selvarajan K; Hasan MR; Chan AP; Jin C; Kim J; Chan SK; Le ND; Kim YB; Tai IT
    Neoplasia; 2012 Jul; 14(7):624-33. PubMed ID: 22904679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
    Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
    Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
    Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
    Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2 overexpression increases malignant potential of human glioma cells through Id1.
    Xu K; Wang L; Shu HK
    Oncotarget; 2014 Mar; 5(5):1241-52. PubMed ID: 24659686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.
    Han M; Xu J; Bi Y; Jiang M; Xu X; Liu Q; Jia J
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):57-65. PubMed ID: 22903384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
    Valcárcel M; Mendoza L; Hernández JJ; Carrascal T; Salado C; Crende O; Vidal-Vanaclocha F
    J Transl Med; 2011 Aug; 9():142. PubMed ID: 21867538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lumbrokinase Extracted from
    Hua C; Guo Z; Dai M; Zhou J; Ge H; Xue G; Xu F; Ru L; Lv K; Zhang G; Zheng L; Wang M; Teng Y; Yu W; Guo W
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells.
    Hou L; Xu B; Guo W; Ran FX; Liu JT; Yuan X; Fu HZ; Cui JR
    J Cancer Res Clin Oncol; 2012 May; 138(5):885-96. PubMed ID: 22314698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
    Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
    Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
    Bhattacharya A; Li Y; Shi Y; Zhang Y
    Carcinogenesis; 2013 Nov; 34(11):2593-9. PubMed ID: 23946495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
    Wang X; Li G; Wang A; Zhang Z; Merchan JR; Halmos B
    Mol Carcinog; 2013 Mar; 52(3):218-28. PubMed ID: 22121107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways.
    Hao Y; Xie T; Korotcov A; Zhou Y; Pang X; Shan L; Ji H; Sridhar R; Wang P; Califano J; Gu X
    Int J Cancer; 2009 May; 124(9):2200-9. PubMed ID: 19123475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms.
    Liu B; Wen JK; Li BH; Fang XM; Wang JJ; Zhang YP; Shi CJ; Zhang DQ; Han M
    Cell Death Dis; 2011 Jul; 2(7):e185. PubMed ID: 21796157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
    Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
    Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premetastatic soil and prevention of breast cancer brain metastasis.
    Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
    Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
    Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
    World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
    Kirane A; Toombs JE; Ostapoff K; Carbon JG; Zaknoen S; Braunfeld J; Schwarz RE; Burrows FJ; Brekken RA
    Clin Cancer Res; 2012 Sep; 18(18):5031-42. PubMed ID: 22829202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer.
    Vaish V; Piplani H; Rana C; Vaiphei K; Sanyal SN
    Mol Cell Biochem; 2013 Jun; 378(1-2):47-64. PubMed ID: 23435960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.
    Li W; Tang YX; Wan L; Cai JH; Zhang J
    Oncol Lett; 2013 Mar; 5(3):923-928. PubMed ID: 23426648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.